How many courses of treatment does Fruquintinib usually take?

The duration of treatment with Fruquintinib (Fruquintinib) is usually based on the patient's specific condition and the type of cancer. This medication is generally available in oral form and the period of use may vary depending on the patient's clinical condition and the recommendations of the physician.

In the treatment of advanced colorectal cancer and gastric cancer, fruquintinib is usually used as part of maintenance therapy to control disease progression and prolong patient survival. The specific number and duration of treatment sessions may vary based on patient response and tolerance.

Generally speaking, after patients receive fruquintinib treatment, doctors will conduct regular evaluations to monitor the tumor response and the patient's overall condition. Treatment may last for several sessions, each of which may span weeks or months. The doctor may adjust the dose or decide whether to continue treatment based on the patient's condition.

In some cases, fruquintinib may also be used in combination with other treatments (such as chemotherapy, radiotherapy, etc.) to achieve better therapeutic effects. The specific plan of this combination treatment will also be individually designed according to the patient's condition.

It needs to be emphasized that as a targeted therapy, the efficacy and tolerability of fruquintinib may vary depending on individual patient differences. Some patients may show a better response to fruquintinib, while others may need longer treatment or seek other treatment options.

Fruquintinib is a drug developed in Hong Kong, China. It has been approved for marketing by the State Food and Drug Administration and has been included in medical insurance. Patients can buy it in domestic hospital pharmacies at a price of about one to two thousand. For specific prices, please consult the local hospital pharmacy.